This map shows the geographic impact of Vida Hamidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vida Hamidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vida Hamidi more than expected).
This network shows the impact of papers produced by Vida Hamidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vida Hamidi. The network helps show where Vida Hamidi may publish in the future.
Co-authorship network of co-authors of Vida Hamidi
This figure shows the co-authorship network connecting the top 25 collaborators of Vida Hamidi.
A scholar is included among the top collaborators of Vida Hamidi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Vida Hamidi. Vida Hamidi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Ohm, Ingrid Kristine, Torunn Elisabeth Tjelle, Christopher James Rose, et al.. (2020). Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment. Duo Research Archive (University of Oslo).1 indexed citations
Couto, Elisabeth, et al.. (2016). Medicines Used for Multiple Sclerosis – A Health Technology Assessment. Duo Research Archive (University of Oslo).4 indexed citations
7.
Sæterdal, Ingvil, et al.. (2016). Health Technology Assessment of Four Drugs for Patients with Metastatic Castration Resistant Prostate Cancer. Duo Research Archive (University of Oslo).2 indexed citations
Pike, Eva, et al.. (2013). Health Technology Assessment of the Different Dialysis Modalities in Norway. Europe PMC (PubMed Central).5 indexed citations
11.
Juvet, Lene Kristine, et al.. (2012). Pemetrexed as Maintenance Therapy for Advanced, Non-Squamous, Non-Small Cell Lung Cancer (NSCLC).
12.
Hamidi, Vida, et al.. (2011). Behandling av pasienter med akutt hjerneslag i slagenheter (med og uten tidlig støttet utskriving). Duo Research Archive (University of Oslo).2 indexed citations
13.
Ringerike, Tove, Vida Hamidi, Gunhild Hagen, Åsmund Reikvam, & Marianne Klemp. (2011). Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery. BIBSYS Brage (BIBSYS (Norway)).2 indexed citations
14.
Hamidi, Vida, et al.. (2011). Utprøving av mini-HTA i Helse Vest RHF. Duo Research Archive (University of Oslo).1 indexed citations
15.
Hamidi, Vida, et al.. (2010). Treatment of Patients with Acute Stroke in Stroke Units (with or without Early Supported Discharge) [Internet].1 indexed citations
16.
Wisløff, Torbjørn, et al.. (2010). Intravenøs trombolytisk behandling av hjerneinfarkt i akuttfasen og sekundær blodproppforebyggende behandling (platehemmende behandling og antikoagulasjonsbehandling) etter hjerneslag. BIBSYS Brage (BIBSYS (Norway)).1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.